Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF
Event: ESC Congress 2020
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Mechanisms of Heart Failure and Implications for Clinical Translation
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction
Event: Heart Failure 2018
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Comorbidities and cardiomyopathies - How to manage?
The Seattle heart failure and proportional risk model for prediction of ICD benefit in non-ischemic cardiomyopathy: A posthoc analysis of the DANISH trial
Event: Heart Failure 2018
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Young Investigator Award: Clinical
Discrepancy in prevalence of impaired glucose regulation and diabetes according to screening method in outpatients with chronic heart failure
Event: Heart Failure 2018
Topic: Comorbidities
Session: Chronic Heart Failure - Clinical
Prognostic value of calculated plasma volume status in patients with heart failure and reduced ejection fraction insights from the PARADIGM-HF trial
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Prognosis
Session: Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis
ESC 365 is supported by
